Medical Care
Global Spinal Muscular Atrophy Genetic Detection Market Research Report 2025
- Jul 08, 25
- ID: 347443
- Pages: 68
- Figures: 70
- Views: 1
The global market for Spinal Muscular Atrophy Genetic Detection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A detection method for Spinal Muscular Atrophy
North American market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Spinal Muscular Atrophy Genetic Detection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Spinal Muscular Atrophy Genetic Detection include United Gene Group, Berrygenomics, Sanvalley, Microread, Genecore, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy Genetic Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy Genetic Detection.
The Spinal Muscular Atrophy Genetic Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spinal Muscular Atrophy Genetic Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spinal Muscular Atrophy Genetic Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Gene Group
Berrygenomics
Sanvalley
Microread
Genecore
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A detection method for Spinal Muscular Atrophy
North American market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Spinal Muscular Atrophy Genetic Detection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Spinal Muscular Atrophy Genetic Detection include United Gene Group, Berrygenomics, Sanvalley, Microread, Genecore, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy Genetic Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy Genetic Detection.
The Spinal Muscular Atrophy Genetic Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Spinal Muscular Atrophy Genetic Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spinal Muscular Atrophy Genetic Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Gene Group
Berrygenomics
Sanvalley
Microread
Genecore
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2020-2031)
2.2 Global Spinal Muscular Atrophy Genetic Detection Growth Trends by Region
2.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Size by Region (2020-2025)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2026-2031)
2.3 Spinal Muscular Atrophy Genetic Detection Market Dynamics
2.3.1 Spinal Muscular Atrophy Genetic Detection Industry Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue (2020-2025)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2020-2025)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spinal Muscular Atrophy Genetic Detection Revenue
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2024
3.5 Global Key Players of Spinal Muscular Atrophy Genetic Detection Head office and Area Served
3.6 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
3.7 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2020-2025)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2026-2031)
5 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2020-2025)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
8.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
9.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
9.4 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
10.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Gene Group
11.1.1 United Gene Group Company Details
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.1.5 United Gene Group Recent Development
11.2 Berrygenomics
11.2.1 Berrygenomics Company Details
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.2.5 Berrygenomics Recent Development
11.3 Sanvalley
11.3.1 Sanvalley Company Details
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.3.5 Sanvalley Recent Development
11.4 Microread
11.4.1 Microread Company Details
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.4.5 Microread Recent Development
11.5 Genecore
11.5.1 Genecore Company Details
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.5.5 Genecore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2020-2031)
2.2 Global Spinal Muscular Atrophy Genetic Detection Growth Trends by Region
2.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Size by Region (2020-2025)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2026-2031)
2.3 Spinal Muscular Atrophy Genetic Detection Market Dynamics
2.3.1 Spinal Muscular Atrophy Genetic Detection Industry Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue (2020-2025)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2020-2025)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Spinal Muscular Atrophy Genetic Detection Revenue
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2024
3.5 Global Key Players of Spinal Muscular Atrophy Genetic Detection Head office and Area Served
3.6 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
3.7 Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2020-2025)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2026-2031)
5 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2020-2025)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
8.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
9.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
9.4 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size (2020-2031)
10.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Gene Group
11.1.1 United Gene Group Company Details
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.1.5 United Gene Group Recent Development
11.2 Berrygenomics
11.2.1 Berrygenomics Company Details
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.2.5 Berrygenomics Recent Development
11.3 Sanvalley
11.3.1 Sanvalley Company Details
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.3.5 Sanvalley Recent Development
11.4 Microread
11.4.1 Microread Company Details
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.4.5 Microread Recent Development
11.5 Genecore
11.5.1 Genecore Company Details
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
11.5.5 Genecore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2020-2025)
Table 11. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2026-2031)
Table 13. Spinal Muscular Atrophy Genetic Detection Market Trends
Table 14. Spinal Muscular Atrophy Genetic Detection Market Drivers
Table 15. Spinal Muscular Atrophy Genetic Detection Market Challenges
Table 16. Spinal Muscular Atrophy Genetic Detection Market Restraints
Table 17. Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players (2020-2025)
Table 19. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2024)
Table 20. Ranking of Global Top Spinal Muscular Atrophy Genetic Detection Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Headquarters and Area Served
Table 23. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 24. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Genetic Detection Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2020-2025)
Table 28. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2026-2031)
Table 30. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2020-2025)
Table 32. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2026-2031)
Table 34. North America Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 49. United Gene Group Company Details
Table 50. United Gene Group Business Overview
Table 51. United Gene Group Spinal Muscular Atrophy Genetic Detection Product
Table 52. United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 53. United Gene Group Recent Development
Table 54. Berrygenomics Company Details
Table 55. Berrygenomics Business Overview
Table 56. Berrygenomics Spinal Muscular Atrophy Genetic Detection Product
Table 57. Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 58. Berrygenomics Recent Development
Table 59. Sanvalley Company Details
Table 60. Sanvalley Business Overview
Table 61. Sanvalley Spinal Muscular Atrophy Genetic Detection Product
Table 62. Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 63. Sanvalley Recent Development
Table 64. Microread Company Details
Table 65. Microread Business Overview
Table 66. Microread Spinal Muscular Atrophy Genetic Detection Product
Table 67. Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 68. Microread Recent Development
Table 69. Genecore Company Details
Table 70. Genecore Business Overview
Table 71. Genecore Spinal Muscular Atrophy Genetic Detection Product
Table 72. Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 73. Genecore Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report
List of Figures
Figure 1. Spinal Muscular Atrophy Genetic Detection Picture
Figure 2. Global Spinal Muscular Atrophy Genetic Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Spinal Muscular Atrophy Genetic Detection Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Reproductive Genetic Testing Features
Figure 6. Diagnostic Test Features
Figure 7. Gene carrier Test Features
Figure 8. Testing Before Symptoms Appear Features
Figure 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Diagnostic Center Case Studies
Figure 14. Spinal Muscular Atrophy Genetic Detection Report Years Considered
Figure 15. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Spinal Muscular Atrophy Genetic Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region: 2024 VS 2031
Figure 18. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players in 2024
Figure 19. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue in 2024
Figure 21. North America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 23. United States Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 27. Germany Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Share by Region (2020-2031)
Figure 35. China Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 43. Mexico Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 47. Turkey Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. United Gene Group Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 51. Berrygenomics Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 52. Sanvalley Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 53. Microread Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 54. Genecore Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Spinal Muscular Atrophy Genetic Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2020-2025)
Table 11. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region (2026-2031)
Table 13. Spinal Muscular Atrophy Genetic Detection Market Trends
Table 14. Spinal Muscular Atrophy Genetic Detection Market Drivers
Table 15. Spinal Muscular Atrophy Genetic Detection Market Challenges
Table 16. Spinal Muscular Atrophy Genetic Detection Market Restraints
Table 17. Global Spinal Muscular Atrophy Genetic Detection Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players (2020-2025)
Table 19. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2024)
Table 20. Ranking of Global Top Spinal Muscular Atrophy Genetic Detection Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Headquarters and Area Served
Table 23. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Product and Application
Table 24. Global Key Players of Spinal Muscular Atrophy Genetic Detection, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Spinal Muscular Atrophy Genetic Detection Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2020-2025)
Table 28. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Type (2026-2031)
Table 30. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2020-2025)
Table 32. Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Application (2026-2031)
Table 34. North America Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2026-2031) & (US$ Million)
Table 49. United Gene Group Company Details
Table 50. United Gene Group Business Overview
Table 51. United Gene Group Spinal Muscular Atrophy Genetic Detection Product
Table 52. United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 53. United Gene Group Recent Development
Table 54. Berrygenomics Company Details
Table 55. Berrygenomics Business Overview
Table 56. Berrygenomics Spinal Muscular Atrophy Genetic Detection Product
Table 57. Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 58. Berrygenomics Recent Development
Table 59. Sanvalley Company Details
Table 60. Sanvalley Business Overview
Table 61. Sanvalley Spinal Muscular Atrophy Genetic Detection Product
Table 62. Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 63. Sanvalley Recent Development
Table 64. Microread Company Details
Table 65. Microread Business Overview
Table 66. Microread Spinal Muscular Atrophy Genetic Detection Product
Table 67. Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 68. Microread Recent Development
Table 69. Genecore Company Details
Table 70. Genecore Business Overview
Table 71. Genecore Spinal Muscular Atrophy Genetic Detection Product
Table 72. Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2020-2025) & (US$ Million)
Table 73. Genecore Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
Table 77. Authors List of This Report
List of Figures
Figure 1. Spinal Muscular Atrophy Genetic Detection Picture
Figure 2. Global Spinal Muscular Atrophy Genetic Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Spinal Muscular Atrophy Genetic Detection Market Share by Type: 2024 VS 2031
Figure 4. Genetic Screening Features
Figure 5. Reproductive Genetic Testing Features
Figure 6. Diagnostic Test Features
Figure 7. Gene carrier Test Features
Figure 8. Testing Before Symptoms Appear Features
Figure 9. Global Spinal Muscular Atrophy Genetic Detection Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Spinal Muscular Atrophy Genetic Detection Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Diagnostic Center Case Studies
Figure 14. Spinal Muscular Atrophy Genetic Detection Report Years Considered
Figure 15. Global Spinal Muscular Atrophy Genetic Detection Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Spinal Muscular Atrophy Genetic Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Spinal Muscular Atrophy Genetic Detection Market Share by Region: 2024 VS 2031
Figure 18. Global Spinal Muscular Atrophy Genetic Detection Market Share by Players in 2024
Figure 19. Global Top Spinal Muscular Atrophy Genetic Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy Genetic Detection as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Spinal Muscular Atrophy Genetic Detection Revenue in 2024
Figure 21. North America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 23. United States Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 27. Germany Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Share by Region (2020-2031)
Figure 35. China Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 43. Mexico Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Share by Country (2020-2031)
Figure 47. Turkey Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Spinal Muscular Atrophy Genetic Detection Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. United Gene Group Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 51. Berrygenomics Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 52. Sanvalley Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 53. Microread Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 54. Genecore Revenue Growth Rate in Spinal Muscular Atrophy Genetic Detection Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232